16-HEM-07-PP (13-601) A Phase 1/2A Open-Label, Multi-Dose, Multi-Center Escalation and Exploratory Study of Cerdulatinib (PRT062070) in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma

  • Saeed, Hayder (PI)
  • Zia, Maryam (Former PI)

Detalles del proyecto

EstadoFinalizado
Fecha de inicio/Fecha fin1/27/171/23/19